Abzyme Therapeutics LLC
3Patents
3Active
3Granted
47Portfolio score
Filing activity: May 22, 2018 → Nov 2, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12116411B2 | Antibodies binding to human CD3 at acidic pH | Chemistry; Metallurgy | 0 | Active |
| US10968444B2 | Methods for generating bispecific functional agents | Chemistry; Metallurgy | 0 | Active |
| US10704040B2 | Triple-mode system for antibody maturation, surface display and secretion | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.